QUEST DIAGNOSTICS INCORPORATED

Lobbying for QUEST DIAGNOSTICS INCORPORATED

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jan 20, 2026.

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$360,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Government bodies contacted 4

Centers For Medicare and Medicaid Services (CMS)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 6

S 1816
Improving Seniors’ Timely Access to Care Act of 2025
HR 3514
Improving Seniors’ Timely Access to Care Act of 2025
HR 5571
Expanding Seniors’ Access to PFAS Testing Act
S 2761
RESULTS Act
HR 5269
RESULTS Act
HR 6363
Further Continuing Appropriations and Other Extensions Act, 2024

Lobbying activity 3

Budget/Appropriations

Appropriations related to clinical laboratory workforce, PFAS and cardiovascular disease testing

Health Issues

Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation Federal price transparency legislation related to clinical laboratories S.1816/H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 H.R. 5571 - Expanding Seniors Access to PFAS Testing Act S.2761 and H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025

Medicare/Medicaid

P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024, provisions related to Medicare reimbursement for clinical diagnostics and pathology laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.